Platanus Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Nuvig Therapeuticsnuvigtx.comDec 2024
Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.
BiotechLongevity
Co-investorsSanofi Venturesabrdn plcAlexandriaB CapitalDigitalis VenturesGlobal BioAccess Fund+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


